Stay updated on ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    PubMed publications description was updated to indicate automatic filling from PubMed, and a revision note shows version v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:15:36.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page no longer displays the government funding lapse notice at the top, and the rest of the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:23:16.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The two screenshots show layout and visual adjustments to the Study Details page; core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T20:50:21.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page now includes a government-funding and operating-status notice and marks a new version (v3.2.0), replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T07:55:52.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0. No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T04:13:01.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element.
    Difference
    0.2%
    Check dated 2025-09-14T21:52:38.000Z thumbnail image

Stay in the know with updates to ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.